Literature DB >> 2306661

The isoelectric focusing properties of serum alkaline phosphatase in disease and following prednisolone and phenylbutazone administration in the horse.

R S Ellison1, R M Jacobs.   

Abstract

This study was undertaken to ascertain if the isoelectric focusing pattern of serum alkaline phosphatase (AP) from sick horses with high activity is useful for determining its tissue origin. The effect of oral prednisolone and phenylbutazone therapy on this enzyme in healthy horses was also investigated. The sick horses were divided into three groups: hepatic, intestinal and miscellaneous. All sera had approximately thirteen bands of AP activity when focused on agarose gels with a pH gradient of 3.5 to 9.5. All the horses in the liver disease group had greater than 65% of enzyme activity in bands 3 to 7 (counted from the anode) whereas the other two groups had at least 30% and up to 80% of activity in bands 8 to 13. This was true even in the several cases of primary intestinal disease that had additional biochemical evidence of liver damage. All bands were heat sensitive indicating that little if any AP was of small intestinal or renal origin. Oral prednisolone and phenylbutazone for 20 and 12 days respectively had no affect on serum AP activity or isoelectric pattern. We concluded that the AP in bands 3 to 7 is of liver origin but the origin of bands 8 to 13 remains undetermined although small intestinal or renal origin is unlikely. Isoelectric focusing of serum AP shows promise in differentiating cases of primary from secondary liver disease but further studies are required correlating serum patterns and tissue patterns in animals with diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306661      PMCID: PMC1255616     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  30 in total

1.  Phenylalanine inhibited p-nitrophenyl phosphatase activity in the serum as an indication of intestinal cellular disruption in the horse.

Authors:  D J Blackmore; A Palmer
Journal:  Res Vet Sci       Date:  1977-09       Impact factor: 2.534

2.  Isoelectric focusing of neuraminidase-treated alkaline phosphatase isoenzymes on agarose gel.

Authors:  C F Root; J S Fine; K J Clayson
Journal:  Clin Chem       Date:  1987-06       Impact factor: 8.327

3.  Experimental ischaemia of the ileum and concentrations of the intestinal isoenzyme of alkaline phosphatase in plasma and peritoneal fluid.

Authors:  J V Davies; E L Gerring; R Goodburn; P Manderville
Journal:  Equine Vet J       Date:  1984-05       Impact factor: 2.888

4.  Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses.

Authors:  J B Taylor; A Walland; P Lees; E L Gerring; T E Maitho; J D Millar
Journal:  Vet Rec       Date:  1983-06-25       Impact factor: 2.695

5.  Diagnostic value of intestinal alkaline phosphatase in horse serum.

Authors:  W E Hoffmann; J L Dorner; H Morris
Journal:  Vet Clin Pathol       Date:  1983       Impact factor: 1.180

6.  Isoenzymes of canine plasma alkaline phosphatase: an investigation using isoelectric focusing and related to diagnosis.

Authors:  P D Eckersall; A S Nash
Journal:  Res Vet Sci       Date:  1983-05       Impact factor: 2.534

7.  Biochemical and haematological effects of phenylbutazone in horses.

Authors:  P Lees; R F Creed; E E Gerring; P W Gould; D J Humphreys; T E Maitho; A R Michell; J B Taylor
Journal:  Equine Vet J       Date:  1983-04       Impact factor: 2.888

8.  Characterization of equine alkaline phosphatase isoenzymes based on their electrophoretic mobility by polyacrylamide gel disc electrophoresis.

Authors:  M B Dumas; J S Spano
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

9.  Liver plasma membrane: the source of high molecular weight alkaline phosphatase in human serum.

Authors:  M E De Broe; F Roels; E J Nouwen; L Claeys; R J Wieme
Journal:  Hepatology       Date:  1985 Jan-Feb       Impact factor: 17.425

10.  Phenylbutazone toxicity in ponies.

Authors:  D H Snow; J A Bogan; T A Douglas; H Thompson
Journal:  Vet Rec       Date:  1979-07-14       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.